Nkarta (NKTX) Change in Cash (2019 - 2026)
Nkarta's quarterly Change in Cash came in at -$12.3 million in Q1 2026, down 149.66% year-on-year from $24.7 million in Q1 2025, and up 40.05% quarter-over-quarter from -$20.5 million in Q4 2025.
Nkarta has reported Change in Cash for 8 years, with the latest figure at -$12.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 149.66% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at -$25.2 million (up 87.23% YoY), and the FY2025 full-year result was $11.8 million, up 471.36% from the prior year.
- Change in Cash for Q1 2026 stood at -$12.3 million, up from -$20.5 million in the prior quarter.
- The five-year high for Change in Cash was $219.2 million in Q1 2024, with the low at -$129.9 million in Q2 2024.
- Average Change in Cash over 5 years is -$1.9 million, with a median of -$7.2 million recorded in 2023.
- Peak annual rise in Change in Cash reached 1255.71% in 2024, while the deepest fall reached 793.69% in 2024.
- Tracing NKTX's Change in Cash over 5 years: stood at -$2.2 million in 2022, then tumbled by 234.35% to -$7.2 million in 2023, then plunged by 302.76% to -$29.1 million in 2024, then advanced by 29.59% to -$20.5 million in 2025, then soared by 40.05% to -$12.3 million in 2026.
- The last three Change in Cash figures came in at -$12.3 million (Q1 2026), -$20.5 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | -12.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.28 Mn |
| Dec 31, 2025 | -20.48 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 816,000.00 |
| Mar 31, 2025 | 24.73 Mn |
| Dec 31, 2024 | -29.09 Mn |
| Sep 30, 2024 | -63.44 Mn |
| Jun 30, 2024 | -129.89 Mn |
| Mar 31, 2024 | 219.25 Mn |
| Dec 31, 2023 | -7.22 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | -24.55 Mn |
| Mar 31, 2023 | 16.17 Mn |
| Dec 31, 2022 | -2.16 Mn |
| Sep 30, 2022 | -91.35 Mn |
| Jun 30, 2022 | 90.04 Mn |
| Mar 31, 2022 | -19.21 Mn |
| Dec 31, 2021 | -35.41 Mn |
| Sep 30, 2021 | 73.45 Mn |
| Jun 30, 2021 | -38.15 Mn |
| Mar 31, 2021 | -34.08 Mn |
| Dec 31, 2020 | -91.88 Mn |
| Sep 30, 2020 | 170.82 Mn |
| Jun 30, 2020 | 1.39 Mn |
| Mar 31, 2020 | -4.10 Mn |
| Dec 31, 2019 | -18.49 Mn |
| Sep 30, 2019 | 33.18 Mn |